Growth stocks offer a once-in-a-lifetime opportunity for generational wealth

With inflation peaking and dovish policy talk rearing its head, Joshua Kalinsky sees a rare opportunity emerging in growth stocks.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Mature friends at a dinner party

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

It has been a difficult year in 2022 to say the least for those looking to accrue wealth by growing their portfolio, with the share prices of growth stocks being brutally punished.

Growth is king

However, across the globe a pattern is emerging, and it revolves around central bank policy and inflation.

In Canada, inflation is falling much sharper than analysts had expected. The UK is seeing faster-than-expected falls in inflation, and the same could be said of the US too.

Whisper it quietly, but the signs are promising that we are moving into a new environment, away from the assumed safe havens of cash ISAs and interest-bearing saving accounts. An environment where growth stocks look to once again take their place on the throne as the king-incumbent.

Pain is a companion of growth

Whilst growth stocks come in all shapes and sizes, by mid-2021 I thought many of the more speculative stocks and sectors had become severely over-priced and in need of a dramatic cut.

So, as I sat at my desk, I wondered what events could take place that would justify a halt in these growth stocks progress.

It came in the manner of supply-chain shocks and war on European soil leading to snow-balling interest rates.

So often, when the consensus perspective believes things are bad (or good) and pain (or jubilation) is being felt in the shape of falling (or rising) prices, the opposite is true.

This is because markets move in anticipation of upcoming events and pain is a necessary component of healing, as any good doctor will tell you.

Greedy when others are fearful, and vice versa

Toward the end of 2022, whilst the doom-and-gloom clouds of hindsight covered world media and policy makers (shaping collective consensus), valuations in some of these growth stocks had reached absurd lows and I thought to myself it’s time to pivot.

Sure enough, inflation began falling earlier and more quickly than consensus expected. Consequently, companies like Tesla that suffered huge drops from their all-time highs began rising from the ashes.

On my buy list

Now don’t get me wrong, I personally won’t be buying Tesla shares for now. But there are now a number of companies with attractive valuations for my portfolio.

For example, one growth stock I’m looking at right now in a sector I’ve been monitoring for bargains is Eco Animal Heath Group.

Like many biotech stocks, its share price has suffered significantly given it’s currently not profitable and is trading very near to its 15-year low — down 70% from its 2021 high.

That being said, I like the approach of the business and growth potential of its products and pipeline. Eco focuses on the prevention and treatment of infectious disease in cattle, poultry, sheep, pigs, horses and dogs.

This is an area that I believe is going to become increasingly important, with infectious diseases on the rise and attention placed on food security, in a warming climate. 

Risk to reward

Investing in growth stocks can be inherently risky at the best of times. But for my portfolio, the time to buy has arrived.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Joshua Kalinsky has no position in any of the shares mentioned. The Motley Fool UK has recommended Tesla. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Passive income text with pin graph chart on business table
Investing Articles

Yields of up to 7%! I’d consider boosting my income with these FTSE dividend stocks

The London market has some decent-looking dividend stocks right now, and I’m tempted by these two for growing income streams.

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

I’d put £20K in an ISA now to target a £1,900 monthly second income in future!

Christopher Ruane shares why he thinks a long-term approach to investing and careful selection of shares could help him build…

Read more »

Mature couple at the beach
Investing Articles

6 stocks that Fools have been buying!

Our Foolish freelancers are putting their money where their mouths are and buying these stocks in recent weeks.

Read more »

Black woman using loudspeaker to be heard
Investing Articles

I was right about the Barclays share price! Here’s what I think happens next

Jon Smith explains why he still feels the Barclays share price is undervalued and flags up why updates on its…

Read more »

Investing Articles

Where I’d start investing £8,000 in April 2024

Writer Ben McPoland highlights two areas of the stock market that he would target if he were to start investing…

Read more »

View of Tower Bridge in Autumn
Investing Articles

Ahead of the ISA deadline, here are 3 FTSE 100 stocks I’d consider

Jon Smith notes down some FTSE 100 stocks in sectors ranging from property to retail that he thinks could offer…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

Why I think Rolls-Royce shares will pay a dividend in 2024

Stephen Wright thinks Rolls-Royce shares are about to pay a dividend again. But he isn’t convinced this is something investors…

Read more »

Investing Articles

1 of the best UK shares to consider buying in April

Higher gold prices and a falling share price have put this FTSE 250 stock on Stephen Wright's list of UK…

Read more »